What If Ventures — Full Portfolio
15 tracked investments · listed companies and verified rows first
Alto Neuroscience is a clinical-stage biopharmaceutical company developing biology-driven medicines for neuropsychiatric conditions, using measurements of brain biology to predict clinical response and identify patients likely to benefit from its drug candidates.
BiotechDigital HealthMental HealthMountain View, US
Amit Etkin(Founder)Adam Savitz(Executive Officer)Nicholas C. Smith(Executive Officer)Michael Hanley(Executive Officer)Aaron Weaver(Director)Po Yu (Jeff) Chen(Director)
PartnerStephen Hays· solo GP
Co-investorsAble PartnersAlpha Wave GlobalInVivium CapitalK2 HealthVenturesKorify CapitalVivo Capital+1 more
AtaiBeckley develops rapid-acting mental health treatments and therapies for patients with difficult-to-treat mental health conditions.
BiotechDeep TechDigital HealthMedical DevicesMental Health
Srinivas Rao(Co-Founder and Chief Executive Officer)Christian Angermayer(Founder and Chairman of the Board)
PartnerStephen Hays· solo GP
Co-investorsAble PartnersAlpha Wave GlobalCatalio Capital Management, LPFJ LabsFuture VenturesLeafy Tunnel+3 more
LSU Health Sciences Center New Orleans is a public academic health institution with six professional schools and eight Centers of Excellence, providing teaching, research, and health care functions.
BiotechDigital HealthEdTechHealthtechNew Orleans, US
PartnerStephen Hays· solo GP
Aeon Industrial develops tactical weapon systems combining autonomous targeting software (ODIN) with modular, rugged hardware, including its Zeus system designed for first-hit lethality against multiple target types.
AI & Machine LearningDefense TechHardware
PartnerStephen Hays· solo GP
Co-investorsAntiMaC Venture CapitalHashkey CapitalIDG CapitalOak Grove VenturesSilent Ventures
Affect Therapeutics operates an app-based digital treatment provider offering care for substance use disorders (alcohol, cannabis, opioid) and mental health conditions like depression and anxiety, using methods such as contingency management, CBT, medication-assisted treatment, and peer support.
Digital HealthHealthtechMental HealthNew York, US
Jeff DeFlavio(Co-founder)inKristin Muhlner(Executive Officer, Director)in
BoardKevin Ryan(Director)Jeff Rinehart(Director)in
PartnerStephen Hays· solo GP
Co-investorsArtis VenturesCity LightAlleyCorpLifeArc VenturesSamsung Next
Allen Control Systems develops autonomous precision weapon systems designed to counter unmanned aerial threats for military and allied forces.
AI & Machine LearningDefense TechRobotics
Mike Wior(CEO)Steve Simoni(President)Luke Allen(CTO)
PartnerStephen Hays· solo GP
Co-investorsCapital FactoryCoalitionCraft VenturesForum VenturesInspired CapitalRally Ventures Management, Llc+3 more
Alto is a digital pharmacy that lets patients send or transfer prescriptions through its app and receive same-day courier or home delivery, with pharmacist support available seven days a week.
ConsumerDigital HealthHealthtech
PartnerStephen Hays· solo GP
Co-investorsAvego BioScience CapitalBantam GroupCalm VenturesCSC UpshotEvolution VC PartnersFlucas Ventures+7 more
AmyriAD Therapeutics is developing Ismidenon (formerly AD101), a once-daily oral small molecule therapy intended to improve cognition and function in patients with Alzheimer's disease.
BiotechLongevity
PartnerStephen Hays· solo GP
Co-investorsElevat3 Capital
Applied Cognition develops neuroscience-based therapeutics and diagnostics, leveraging AI and deep expertise in drug development and clinical research for neurological disorders.
AI & Machine LearningBiotechDeep TechHealthtech
Paul Dagum(CEO & Co-founder)Jake Winebaum(Executive Chairman & Co-founder)
PartnerStephen Hays· solo GP
Co-investorsGreyMatterMayfield FundSupermoon Capital
HealthtechSaratoga Springs, US
Daniel T. Pickett III(Executive Officer, Director)Timothy Koehler(Executive Officer)Greg Stephen(Executive Officer)
BoardHolly Benson(Director)Mary Langowski(Director)Peter Dorsman(Director)
PartnerStephen Hays· solo GP
Co-investorsClaritas CapitalTakeda Ventures
AtaiBeckley develops rapid-acting and durable mental health treatments for patients with difficult-to-treat mental health conditions.
BiotechMedical DevicesMental Health
Christian AngermayerSrinivas Rao
PartnerStephen Hays· solo GP
Co-investorsFJ LabsIter InvestmentsLeafy TunnelNoeticRedbus Ventures
PartnerStephen Hays· solo GP
Co-investorsBold Capital PartnersCompoundDeep InsightFlucas VenturesDolby Family Ventures
Firehawk Aerospace manufactures solid rocket motors, energetic materials, and propellant using additive (3D printing) manufacturing to produce propellant grains and hybrid rocket engine components.
Defense TechHardwareSpace TechWilmington, US
Will Edwards(Cofounder)Andrew Wills Edwards(Executive Officer)
PartnerStephen Hays· solo GP
Co-investorsBackswing VenturesCathexis VenturesDecisive PointPlains VenturesRed Beard VenturesVictorum+3 more
Raven Space Systems develops Microwave Assisted Deposition (MAD) 3D printing technology to manufacture aerospace-grade thermoset and ceramic composite structures, thermal protection, and related parts.
Advanced ManufacturingDefense TechSpace Tech
Ryan Cowdrey(Cofounder)Blake Herren(Cofounder)
Co-investorsCapital FactoryFortySix Venture CapitalBackswing Ventures
Umbra designs, builds, tests, and operates satellite systems with precision radar imagery capabilities for space-based missions and intelligence applications.
Deep TechDefense TechSpace TechSanta Barbara, US
David Langan(CEO, Co-founder)Gabe Dominocielo(Executive Officer, Director)
BoardJohn Burbank(Director)
PartnerStephen Hays· solo GP
Co-investors7BC Venture CapitalChampion Hill VenturesCrosscut VenturesDefense AngelsHemisphere Ventures LLCNimble Partners+6 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.